Claxton DF - Search Results

1

Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia.

Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB. Claxton DF, et al. Blood. 1992 Aug 1;80(3):582-6. Blood. 1992. PMID: 1353379 Free article.

2

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.

Claxton D, Deisseroth A, Talpaz M, Reading C, Kantarjian H, Trujillo J, Stass S, Gooch G, Spitzer G. Claxton D, et al. Blood. 1992 Feb 15;79(4):997-1002. Blood. 1992. PMID: 1371081 Free article.

3

Retinoids and cancer therapy.

Claxton DF, Plunkett W Jr, Andreeff M, Deisseroth AB. Claxton DF, et al. J Natl Cancer Inst. 1992 Sep 2;84(17):1306-7. doi: 10.1093/jnci/84.17.1306. J Natl Cancer Inst. 1992. PMID: 1495098 No abstract available.

4

Molecular analysis of retroviral transduction in chronic myelogenous leukemia.

Claxton D, Suh SP, Filaccio M, Ellerson D, Gaozza E, Andersson B, Brenner M, Reading C, Feinberg A, Moen R, et al. Claxton D, et al. Hum Gene Ther. 1991 Winter;2(4):317-21. doi: 10.1089/hum.1991.2.4-317. Hum Gene Ther. 1991. PMID: 1665348 Free article.

5

Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemia.

Claxton D, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU, Talpaz M. Claxton D, et al. Acta Haematol. 1990;83(3):149-51. doi: 10.1159/000205193. Acta Haematol. 1990. PMID: 2109455

6

Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation.

Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, Gajewski J, Khouri I, van Besien K, Andersson B, et al. Ippoliti C, et al. Urology. 1995 Dec;46(6):811-5. doi: 10.1016/s0090-4295(99)80349-5. Urology. 1995. PMID: 7502421 Clinical Trial.

7

Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.

Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, et al. Deisseroth AB, et al. Blood. 1994 May 15;83(10):3068-76. Blood. 1994. PMID: 7514051 Free article.

8

Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.

Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I, et al. Talpaz M, et al. Blood. 1995 Jun 1;85(11):3257-63. Blood. 1995. PMID: 7756658 Free article.

9

Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.

Marlton P, Claxton DF, Liu P, Estey EH, Beran M, LeBeau M, Testa JR, Collins FS, Rowley JD, Siciliano MJ. Marlton P, et al. Among authors: claxton df. Blood. 1995 Feb 1;85(3):772-9. Blood. 1995. PMID: 7833479 Free article.

10

Genetic therapy of human neoplastic disease.

Deisseroth AB, Hanania EG, Fu S, Claxton D, Andreeff M, Champlin R, Kavanagh J, Hortobagyi G, Holmes F, Reading C, et al. Deisseroth AB, et al. J Hematother. 1993 Fall;2(3):373-5. doi: 10.1089/scd.1.1993.2.373. J Hematother. 1993. PMID: 7921999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters